Safety Exposure‐Response Analysis for Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV‐Infected Subjects

類似資料

• Population Pharmacokinetic Analysis for Daclatasvir and Asunaprevir in Japanese Subjects With Chronic Hepatitis C Virus Infection
  著者:: Osawa, Mayu, 等
  出版事項: (2018)
• Exposure‐Response (Efficacy) Analysis of Daclatasvir and Asunaprevir in Japanese Patients With Hepatitis C Virus Infection
  著者:: Ueno, Takayo, 等
  出版事項: (2018)
• Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection
  著者:: Zhu, Li, 等
  出版事項: (2018)
• Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects
  著者:: Garimella, Tushar, 等
  出版事項: (2017)
• Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid
  著者:: de Ruiter, Petra E, 等
  出版事項: (2018)